| Literature DB >> 27536197 |
Gehan Moubarz1, Mohamed A Embaby2, Nada M Doleib3, Mona M Taha4.
Abstract
Diabetic patients are at risk of acquiring infections. Chronic low-grade inflammation is an important factor in the pathogenesis of diabetic complication. Diabetes causes generation of reactive oxygen species that increases oxidative stress, which may play a role in the development of complications as immune-deficiency and bacterial infection. The study aimed to investigate the role of a natural antioxidant, cumin, in the improvement of immune functions in diabetes. Diabetes was achieved by interperitoneal injection of streptozotocin (STZ). Bacterial infection was induced by application of Staphylococcus aureus suspension to a wound in the back of rats. The antioxidant was administered for 6 weeks. Results revealed a decrease in blood glucose levels in diabetic rats (p < 0.001), in addition to improving immune functions by decreasing total IgE approaching to the normal control level. Also, inflammatory cytokine (IL-6, IL-1β and TNF) levels, as well as total blood count decreased in diabetic rats as compared to the control group. Thus, cumin may serve as anti-diabetic treatment and may help in attenuating diabetic complications by improving immune functions. Therefore, a medical dietary antioxidant supplementation is important to improve the immune functions in diabetes.Entities:
Keywords: Cuminum cyminum; Staphylococcus aureus; diabetes; immunity; streptozotocin (STZ)
Year: 2016 PMID: 27536197 PMCID: PMC4967646 DOI: 10.5114/ceji.2016.60985
Source DB: PubMed Journal: Cent Eur J Immunol ISSN: 1426-3912 Impact factor: 2.085
Fig. 1The serum level of glucose and nitric oxide in diabetic, infected groups (GIII, GIV & GV) and cumin supplemented groups (GIII*, GIV* & GV*)
Fig. 2The serum level of cytokines and total IgE in diabetic, infected groups (GIII, GIV& GV) and cumin supplemented groups (GIII*, GIV* & GV*)
Effect of cumin oil on total leukocyte count (TLC) and differential blood count
| Group | TLC | Lymphocyte | Segmented |
|---|---|---|---|
| Normal control (GI) | 7.97 ±1.01 | 58.67 ±6.1 | 41.33 ±5.89 |
| Normal control + cumin (GII) | 6.88 ±0.99 | 48.8 ±5.2 | 51.2 ±5.53 |
| Diabetic control (GIII) | 12.37 ±3.13 | 78.67 ±9.5 | 21.33 ±4.37 |
| Infected group (GIV) | 14.87 ±3.13 | 79.93 ±5.65 | 20.07 ±4.37 |
| Infected diabetic group (GV) | 15.65 ±6.58 | 80.83 ±5.88 | 19.17 ±8.89 |
| Diabetic control + cumin (GIII*) | 10.52 ±2.01 | 67.33 ±12.6 | 32.67 ±4.86 |
| Infected group + cumin (GIV*) | 12.57 ±2.93 | 72.26 ±11.7 | 27.74 ±3.97 |
| Infected diabetic group + cumin (GV*) | 11.73 ±2.99 | 73.17 ±6.52 | 26.83 ±9.99 |
Data expressed as mean ± SE
p < 0.001 vs. normal control
p < 0.001 vs. diabetic control
p < 0.05 vs. infected control
p < 0.05 vs. infected diabetic group